期刊文献+

暖宫种子汤治疗多囊卵巢综合征疗效观察 被引量:3

Clinical study on treatment of polycystic ovary syndrome with nuangongzhongzi recipe
下载PDF
导出
摘要 目的观察暖宫种子汤对多囊卵巢综合征(polycystic ovarian syndrome,PCOS)促排卵的临床疗效。方法收集符合PCOS纳入标准的患者90例,随机分为暖宫种子汤(A组)、克罗米芬组(B组)和联合用药组(C组)各30例。记录卵泡发育、子宫内膜生长、宫颈黏液性状、基础和促排卵治疗后性激素、胰岛素等指标。结果A组和C组的子宫内膜厚度和宫颈黏液评分优于B组,注射HCG日B组和C组的卵泡直径大于A组,差异有显著性(P<0.05)。各组排卵率分别为59.26%、66.67%和73.33%,差异均无显著性(P>0.05)。结论暖宫种子汤能有效诱导PCOS患者排卵,与克罗米芬合用能改善对子宫内膜和宫颈黏液的不利影响。 Objective To study the effect of Nuangongzhongzi Recipe on polycystic ovary syndrome (PCOS). Methods Ninety PCOS patients were randomly divided into 3 groups: Nuangongzhongzi recipe group( group A ,30 cases treated with Chinese traditional medicine) , the clomiphene citrate group (group B ,30 cases, treated with clomiphene citrate) and group C( 30 cases, treated with clomiphene citrate and Chinese traditional medicine). The follicle figures and endometrial diameter were recorded, and the sex hormone and insulin level were determined before and after treatment.Results The ovulation rate of these three groups was 59. 26% ,66. 67% and 73.33% respectively. No significant differ- ence of ovulation rate was found between the three groups. The endometrial diameter and cervical Insler's scores were significantly higher in group A and group C than that in group B. Conclusion The Chinese traditional medicine- Nuangongzhongzi recipe can raise ovulation rate, and significantly reduce the side effects of clomiphene citrate in PCOS patients.
出处 《广东医学》 CAS CSCD 北大核心 2009年第4期635-637,共3页 Guangdong Medical Journal
基金 广东省中医药管理局基金资助项目(编号:1060033)
关键词 多囊卵巢综合征 暖宫种子汤 排卵 polycystic ovary syndrome nuangongzhongzi recipe ovulation
  • 相关文献

参考文献5

二级参考文献36

  • 1魏美娟,俞瑾.补肾中药对雄激素致不孕大鼠肾上腺皮质形态学观察[J].中国中西医结合杂志,1994,14(12):736-738. 被引量:40
  • 2俞瑾 杨淑萍 等.雄激素致高胰岛素高雄激素无排卵大鼠模型[J].生殖医学杂志,1993,2:251-259.
  • 3张月萍 俞瑾 等.雄激素致不孕大鼠发病机制及滋肾阴药对其促排卵作用[J].中华内分泌代谢杂志,1994,10:98-101.
  • 4Bayram N, v. W. M, Vandekerckhove P, et al. Pulsatile luteinising hor-mone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome. Coehrane Database Syst Rev. 2003, (3).CD000412.
  • 5Imani B, E. M, Faessen GH, Bouchard P, et al. Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety,and efficiency. Fertil Steril,2002,77:83 - 90.
  • 6Bayram N, v. W. M, van Der Veen F. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev ,2001, CD002121.
  • 7Gleicher, N, Vietzke, M., Vidali, A. Bye-bye urinary gonadotrophins?Recombinant FSH: A real progress in ovulation induction and IVF? Hum Reprod, 2003,18(3) :476 - 482.
  • 8Mulders AG, Laven JS, Eijkemans MJ et al. Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Hum Reprod Update, 2003, Sep-Oct,9(5) :429 - 449.
  • 9Hugues E, C. J, Vanderkerckhove P. Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin therapy for clomiphene resiststant PCOS. Cochrane Database Syst Rev, 2000,CD000087.
  • 10Nugent D, V. P, Hughes E, Amot M, Lilford R. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev, 2000, (4) : CD000410.

共引文献62

同被引文献13

引证文献3

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部